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Abstract
Background: Control of growth rate is mediated by tight regulation mechanisms in all free-living organisms since
long-term survival depends on adaptation to diverse environmental conditions. The yeast, Saccharomyces cerevisiae,
when growing under nutrient-limited conditions, controls its growth rate via both nutrient-specific and nutrient-
independent gene sets. At slow growth rates, at least, it has been found that the expression of the genes that
exert significant control over growth rate (high flux control or HFC genes) is not necessarily regulated by growth
rate itself. It has not been determined whether the set of HFC genes is the same at all growth rates or whether it
is the same in conditions of nutrient limitation or excess.
Results: HFC genes were identified in competition experiments in which a population of hemizygous diploid yeast
deletants were grown at, or close to, the maximum specific growth rate in either nutrient-limiting or nutrient-
sufficient conditions. A hemizygous mutant is one in which one of any pair of homologous genes is deleted in a
diploid, These HFC genes divided into two classes: a haploinsufficient (HI) set, where the hemizygous mutants
grow slower than the wild type, and a haploproficient (HP) set, which comprises hemizygotes that grow faster
than the wild type. The HI set was found to be enriched for genes involved in the processes of gene expression,
while the HP set was enriched for genes concerned with the cell cycle and genome integrity.
Conclusion: A subset of growth-regulated genes have HFC characteristics when grown in conditions where there
are few, or no, external constraints on the rate of growth that cells may attain. This subset is enriched for genes
that participate in the processes of gene expression, itself (i.e. transcription and translation). The fact that
haploproficiency is exhibited by mutants grown at the previously determined maximum rate implies that the
control of growth rate in this simple eukaryote represents a trade-off between the selective advantages of rapid
growth and the need to maintain the integrity of the genome.
Background
Appropriate control of the rate of cell growth is central
to the long-term survival of species, particularly micro-
organisms. A fast growth rate is a competitive advantage
when environmental conditions are favourable, while
slow growth or even quiescence may allow survival
under stress conditions such as rapid changes in the
physicochemical environment, starvation, or exposure to
toxins. Thus most organisms have evolved stringent
controls over the rate of cell growth, and any disruption
of these controls has severe consequences; an obvious
example being the development of cancer as a result of
uncontrolled cell division.
Our genome-scale approach to the investigation of
growth rate control in the model eukaryote cell, S. cere-
visiae, is based on the concepts of Metabolic Control
Analysis (MCA; [1]). MCA defines the extent of control
exerted over the flux through a pathway by its compo-
nents. In our context, flux is the growth rate of cells,
pathway components are the gene products, and control
coefficients are the ratios of the fractional changes in
growth rate to the fractional changes in the concentra-
tions of gene products. Thus the term “control” has a
special meaning in the context of MCA. Those cell
components that exert control over flux are not necessa-
rily regulatory molecules. Rather, they exert control
because the flux through the pathway is sensitive to
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changes in the concentration (or activity) of the compo-
nent. In this paper, we shall routinely use the term
‘growth rate’, rather than ‘flux’, since we have measured
differences in growth rate consequent on reducing the
copy number of individual genes from two to one in
diploid yeast.
As part of our overall approach, we have designed
experiments in two categories to elucidate the control
coefficients of gene products for growth rate. In Cate-
gory 1 experiments, we measured the change in the con-
centration of gene products as a response to a change in
flux ([2];[3]). We report no new Category 1 experiments
in the present study, but we shall refer to our earlier
experiments in this Category. In Category 2 experi-
ments, the concentration of gene products is altered and
any impact on growth rate measured [4]; all new data
reported in this paper relates to Category 2 experiments.
In our earlier Category 1 experiments, we grew a
reference yeast strain in carbon-, nitrogen-, phosphorus-
, or sulphur-limited conditions in chemostat culture at
dilution rates, D = 0.07, 0.1 and 0.2 h-1 (equivalent to
doubling times ~ 10, 7, and 3.5 h, respectively), and col-
lected samples at each of the different steady states. We
analysed our samples for changes in the levels of
mRNAs, proteins, and metabolites with respect to dilu-
tion rate and identified a set of growth-rate-regulated
(GR) genes; i.e. a set of genes that significantly changed
their expression levels in response to the change in
growth rate, irrespective of the specific nutrient whose
rate of supply determined the rate of growth [2]. There
is also a nutrient-regulated (NR) gene set, whose expres-
sion levels change according to the nutrient whose rate
of supply is determining the growth rate; again, we have
reported on these previously [3]. The level of expression
of NR genes may vary in either a growth-rate-dependent
or growth-rate-independent manner.
In the set of Category 2 experiments that we reported
previously, we established a growth-rate competition
between yeast deletion mutants (each hemizygous for
just one of the organisms 5,800 protein-encoding genes
[5]) under carbon, nitrogen, or phosphorus limitation in
chemostats at D = 0.1 h-1 [4]. We classified all the
mutants according to the sign of their relative growth
rate, the mutants with negative relative growth rate (i.e.
whose proportion in the population fell significantly
overtime) were classified as haploinsufficient (HI) and
the mutants with positive relative growth rate (i.e.
whose proportion in the population significantly
increased with time) were classified as haploproficient
(HP). The set of haploinsufficient and haploproficient
genes together form the set of high flux control (HFC)
genes, i.e. those genes for which a reduction of their
copy number in diploid cells from 2 to 1 results in a sig-
nificant change in growth rate (flux).
Our earlier results showed that, under all three nutri-
ent limitations and at a dilution rate of 0.1 h-1, there
was little overlap between HFC genes from Category 2
experiments and the GR genes defined in Category 1
experiments; i.e. the genes regulated by growth rate are
not, themselves, regulators of growth. At the time [4],
we noted that this result might, in the jargon of Systems
Biology, represent a ‘design rule’ for the eukaryotic cell.
However, since cells are the products of evolution rather
than design, such rules may change according to the
selection pressures to which an organism is exposed.
Thus, while this rule about HFC genes holds for nutri-
ent-limited environments, further studies are required to
determine whether it has any greater generality. This
paper reports these additional studies.
Since our previous set of Category 2 experiments was
carried out at a low growth rate and under nutrient lim-
itation, we decided to determine whether the lack of
overlap between HFC and GR gene sets still held at high
growth rates or under nutrient-unconstrained conditions.
Chemostats tend to be unstable at dilution rates close to
the cells’ maximum specific growth rate (μmax) and so, to
establish a steady state at μmax, we used turbidostats to
allow us to monitor competition between the pool of
hemizygous yeast deletants growing in a complex syn-
thetic medium (FPM [6]; see Methods section for modifi-
cations). Turbidostats are continuous cultures in which
the cells, rather than the experimenter, control the
growth rate [7] since the nutrient supply is determined
by the biomass concentration in the growth vessel.
Accordingly, we established a turbidostat in which the
biomass concentration was held at a value equivalent to
that of a mid-exponential phase batch culture. The turbi-
dostat is unconstrained by the supply of nutrients and so
equilibrates at the maximum specific growth rate of the
yeast strain used. However, if the culture is a pool of
hemizygous mutants of S. cerevisiae, and if the different
mutants in the pool can have different maximum growth
rates, those mutants that can achieve a μmax greater than
the population average will increase in the population
over time, while those with a μmax less than the popula-
tion average will decrease in the population. (Those read-
ers unfamiliar with chemostats and turbidostats will find
a fuller explanation in Additional File 1, Additional Text;
also see reviews by Bull [8] and Pirt [7].)
Turbidostats, just like chemostats, represent a sensitive
way of identifying haploinsufficient and haploproficient
phenotypes, with the difference that (in a turbidostat) hap-
loproficient mutants must be capable of growing at a rate
greater than the previously recorded μmax. Thus, in this
study, we have searched for sets of genes that exhibit
either haploinsufficient or haploproficient phenotypes
(these are both sub-sets of the class of HFC genes) in
rapidly growing yeast cultures, either in nutrient-limited
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chemostats operated at D-values close to μmax or in the
nutrient-unconstrained conditions of turbidostat culture.
Further, we investigated subsets of HFC genes that have
closely related cellular functions in order to elucidate the
gene and protein features that mediate their high degree
of control over growth rate. Finally, we propose an
extended approach to growth rate (or flux) control, with-
out limiting its definition to enzymes or haploinsufficiency.
Results
Genes showing high growth-rate control during rapid
growth in nutrient-unconstrained conditions
After monitoring the competitive growth of the mutants
in the turbidostat for about 30 generations, we calcu-
lated the relative change in the log.-transformed abun-
dance of mutants in the pool with respect to time:
FCC′ =
d(lnX)
dt
(see Methods section for derivation).
The mutants were then classified according to the sign
of their relative growth rate. 796 mutants were identified
with a positive slope (FDR < 0.05). These grew faster
than the population average and are defined as haplo-
proficient. 1932 mutants grew slower than the popula-
tion average (FDR < 0.05) and are defined as
haploinsufficient. In total, 2728 HFC genes were found
for which the changes in the relative concentrations of
their hemizygotes were not significant (see Additional
File 1, Additional Text; Additional File 2, Figure S1;
Additional File 3, Table S1).
We examined whether particular functional classes of
genes were enriched among the HI and HP sets using
GO terms [9] and logistic regression [10] (Table 1; see
Additional File 4, Table S2 for complete results for GO
terms). Genes associated with the processes of transcrip-
tion and translation, e.g. genes that encode cytosolic
ribosomal proteins and the components of the RNA
polymerase I, II, and III complexes were enriched in the
Table 1 GO terms enriched among HFC control (see Additional File 4, Table S2 for complete list of GO terms)
ENRICHED HAPLOINSUFFICIENT SET
GO ID GO term Ontology Number of genes FDR
GO:0005840 ribosome CC 287 3.55E-018
GO:0030880 RNA polymerase complex CC 31 6.83E-016
GO:0055029 nuclear DNA-directed RNA polymerase complex DNA-directed RNA polymerase II, core CC 31 6.83E-016
GO:0005665 DNA-directed RNA polymerase II, core complex CC 12 3.51E-014
GO:0016591 DNA-directed RNA polymerase ll, holoenzyme CC 70 4.70E-012
GO:0032991 Macromolecular complex CC 1538 4.22E-010
GO:0005736 DNA-directed RNA polymerase I complex CC 14 4.23E-006
GO:0005832 chaperonin-containing T-complex CC 11 1.57E-005
GO:0005666 DNA-directed RNA polymerase III complex CC 17 2.18E-005
GO:0032200 telomere organization and biogenesis BP 260 4.25E-005
GO:0042254 ribosome biogenesis and assembly BP 334 9.79E-005
GO:0000119 mediator complex CC 21 0.000265
GO:0005838 proteasome regulatory particle CC 20 0.014216
GO:0030528 transcription regulator activity MF 335 0.014216
GO:0004175 endopeptidase activity MF 77 0.027946
ENRICHED HAPLOPROFICIENT SET
GO ID GO term Ontology Number of genes FDR
GO:0007049 cell cycle BP 552 0.002534
GO:0051320 S phase BP 20 0.003251
GO:0006260 DNA replication BP 151 0.010963
GO:0015932 nucleobase, nucleoside, nucleotide and nucleic acid transmembrane transporter activity MF 13 0.017113
GO:0000082 G1/S transition of mitotic cell cycle BP 52 0.023716
GO:0005669 transcription factor TFIID complex CC 14 0.034692
GO:0005685 snRNP U1 CC 15 0.035741
GO:0051052 regulation of DNA metabolic process BP 41 0.043266
GO:0016020 membrane CC 1592 0.044202
GO:0005991 trehalose metabolic process BP 10 0.050603
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HI gene set at a high level of significance (P < 10-5).
Apart from the functional categories, it was also noted
that genes whose products are members of macromole-
cular complexes were highly enriched in the HI set (P <
10-9). This was true even if genes encoding ribosomal
proteins were excluded from the HI set.
Analysis of the smaller set of HP genes from the tur-
bidostat selection showed that the over-represented
functional categories included the cell cycle (e.g. spindle
checkpoint genes) and macromolecule storage (e.g.
genes encoding proteins involved in trehalose metabo-
lism). The fraction of HFC genes in various organelles,
selected protein complexes and cellular processes is
shown in Additional File 5, Figure S2.
HFC at rapid growth in comparison to nutrient-limited
chemostats at low growth rates
Results from the present study demonstrate that the
functional distribution of HFC genes detected by com-
petitions in turbidostats is very different from the HFC
genes detected by our earlier Category 2 experiments
[4] that involved competitions in nutrient-limited che-
mostats. However, it is not clear if this difference is a
result of nutrient availability or growth rate, since the
experiments by Delneri and co-workers were performed
at a relatively slow growth rate (D = 0.1 h-1), while cells
in a turbidostat grow at their maximum rate. To address
this question, we carried out additional competition
experiments aimed at distinguishing between the impact
of fast growth and that of nutrient sufficiency (See
Figure 1A for the experimental design).
First, a yeast culture in synthetic complete medium
(FPM) was grown in chemostat mode at D = 0.3 h-1.
This means the same growth conditions were applied as
in the turbidostat except that the cells were growing at
a fixed dilution rate close to the maximum specific
growth rate. The dilution rate in the turbidostats, and
hence the maximum growth rate of the pool, stabilised
at 0.32 h-1. However, 0.3 h-1 was used in the chemostat,
because operating at 0.32 h-1 would be at the limit of
the stability for a chemostat culture of the pool of
mutants. We found that the set of HFC genes detected
under these conditions was very similar to the set
detected in turbidostat competitions (Additional File 3,
Table S1). Thus, similar sets of HFC genes were found
at similar growth rates despite the fact that one culture
was nutrient-limited (the chemostat with FPM is leu-
cine-limited), while the other was nutrient sufficient
(turbidostat).
Next, we carried out competitions in ammonium-lim-
ited chemostats at higher dilution rates (D = 0.2 h-1 and
0.3 h-1). We will refer to these two conditions as N02
and N03, respectively, with a nitrogen-limited chemostat
at D = 0.1 h-1 being termed N01; correspondingly
cultures grown in FPM are termed FPMT, if run in tur-
bidostatic mode, and FPM03, if run as a chemostat at D
= 0.3 h-1. First of all, the results demonstrated that the
HFC genes detected under nitrogen limitation vary con-
siderably at different dilution rates. The correlation of
FCC’s (Figure 1B) from N01 and N02 is 0.54, indicating
that most mutants behave similarly under the two con-
ditions, however when dilution rate is increased further
to 0.3, the similarity disappears. Competitions with dif-
ferent nutrient limitations (C01, N01 and P01) are
highly correlated to each other at a slow growth rate,
and cluster together on the dendrogram. The fast-
growth rate experiments cluster together (FPMT,
FPM03 and N03) and are highly correlated to each
other. Hence the major difference between the competi-
tions is the rate of growth achieved, rather than the
nutrients being in plentiful or limiting supply.
Genetic control of growth rate is qualitatively, but not
quantitatively, correlated with, growth rate regulation of
gene expression
Previously, we have shown that genes involved in the
processes of gene expression are highly up-regulated at
high growth rates (GR genes from Category 1 experi-
ments, [2]). These significantly up-regulated genes show
extensive identity to genes identified as HI at high
growth rates (hypergeometric p < 10-5) and are highly
underrepresented in the set of HP genes (hypergeo-
metric p < 10-32) (Figure 2A). However, while the degree
of overlap between the GR and HI gene sets is high, we
find that (in quantitative terms) the fold change of up-
regulation in gene expression is only weakly correlated
to the FCC values (rho = -0.15) (Figure 2B). This
demonstrates that, although growth-regulated genes are,
themselves, controllers of growth rate at the fastest
growth rates, there is no simple relationship between
the change in growth rate due to haploinsufficiency and
the fold change in transcript level or protein concentra-
tion of those same HI genes at different growth rates.
It should be noted that, although Category 1 experi-
ments showed the transcript levels of genes encoding
components of the mitochondrial ribosome to be up-
regulated as a function of growth rate in chemostats, the
competition experiments in turbidostats did not indicate
that any growth-rate control was exerted by these com-
ponents. Although mitochondrial activity has long been
known to be an important factor that affects the growth
rate in yeast (e.g. respiratory-deficient petite mutants are
slow-growing [11]), our competition experiments do not
suggest that genes encoding mitochondrial proteins exert
any significant growth-rate control. Expression of the
mitochondrial ribosomal proteins were up-regulated in
C-limited chemostats at high dilution rates [2], indicating
high levels of respiration were taking place at higher
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dilution rates under carbon limitation. The lack of
growth-rate control by mitochondria in our experiments
could be an outcome of the high glucose concentration
in both the turbidostat and the nitrogen-limited chemo-
stat at D = 0.3 h-1, where excess glucose would repress
respiration and promote fermentation.
Range of flux control varies among genes within the
same functional category
The control of growth rate by genes involved in large
cellular components can be of different strength or even
of negative directions. For example genes encoding the
proteins located in nucleus or in mitochondrion can
have a large range of FCC’s, spanning from positive
FCC’s with large magnitude to negative FCC’s with large
magnitude, including the ‘weak range’, where FCC’s are
very close to zero but still are significant (Figure 3).
However, even protein complexes specialized on a single
function, like ribosomes, can have components with a
large range of FCC’s.
Most protein complexes are essential for viability,
though not every component of a given complex is
essential. By analogy, it can be hypothesized that most
protein complexes exert growth-rate control when cells
Figure 1 Experimental design and correlation of growth profiles in different conditions. A: Competition in carbon-, nitrogen- or
phosphorus-limited (F1) chemostats operating at 0.1 h-1 [4] were initially compared to competition in turbidostat cultures using complete
synthetic medium (FPM, [6]; this work). Nitrogen-limited chemostat experiments at 0.2 h-1 and 0.3 h-1 (this work) and FPM fed chemostat at 0.3
h-1 (this work) were designed to investigate the differences between the competition in nutrient-limited chemostats operated at low growth
rates to competition in the high growth-rate nutrient-sufficient conditions of the turbidostat. B: Correlation matrix based on the Spearman
correlation coefficient of the relative growth rates of each hemizygote obtained from each experiment. The dendrograms are calculated using
the Euclidean distance between rows (experiments) and hierarchical clustering.
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are growing rapidly, though not every gene that encodes
a component of a particular has a significant flux con-
trol coefficient (FCC’). We have selected a subset of pro-
tein complexes and cellular processes to exemplify the
range of FCC’ values in turbidostats (Figure 3; Addi-
tional File 5, Figure S2). A highly haploinsufficient small
protein complex like RNA polymerase I, can include a
few HP genes with a small range of FCC’s, while the
genes encoding the rest of its subunits have a large
range of negative growth-rate control coefficients. More-
over, the average FCC’ values for members of different
multiprotein complexes was found to vary in turbidostat
competitions. For instance, genes encoding sub-units of
the COPI vesicle coat and the exosome have high aver-
age positive FCC’ values, while those encoding compo-
nents of the RNA polymerase I complex and the
chaperonin-containing T-complex have high average
negative FCC’s.
Genes with functions involved in the cell cycle and the
maintenance of genome integrity are associated with
haploproficiency
Genes involved in the cell cycle that determine the G1/S
phase transition and progression through S phase were
particularly enriched in our set of haploproficient genes.
A subset of cell cycle related genes are expressed peri-
odically as the cell cycle progresses [12] and regulated
post-transcriptionally by a sequence of events [13]
including ‘just-in-time assembly’ [14]. A reduction in the
copy number of some of these genes in the results in
growth rate above μmax in turbidostats (Additional File
3, Table S1). This indicates that a reduction of controls
that delay the cell cycle under normal conditions can, in
fact, allow the cycle proceed more quickly in these HP
hemizygotes.
Having observed that cell-cycle functions were asso-
ciated with haploproficiency at higher growth rates, we
measured (for 120 hemizygotes), the proportional distri-
bution of cells in different phases of the cell cycle
(Figure 4). Previously, wild-type cells growing in chemo-
stats at different growth rates were reported to have the
length of their unbudded G1 or G0 phase negatively
correlated with their growth rate [15]. We compared the
G1-phase enrichment of the 120 mutants to their flux
control coefficients in turbidostat culture, and found no
significant correlation (rho = -0.14, p-value = 0.14). This
demonstrated that the haploproficiency of these mutants
is not an immediate result of a shortened G1-phase.
Amongst those mutants that showed a large change in
their cycle maps were deletants of CDC28 and two
cyclin genes, CLB2 and CLN3, whose products promote
the G2/M and G1/S transitions, respectively [16,17].
Both CLN3 and CDC28 were HP at high growth rates,
suggesting a link between altered progress through the
cycle and faster growth. We have selected a subset of 9
genes that control the G2/M transition to investigate
their effect on progress of cell cycle and phenotype in
tetraploid deletion mutants (Alcasabas and co-workers,
submitted). Other genes showing both haploproficiency
and an altered cell cycle included DMA2, whose human
Figure 2 Comparison of FCC’s of genes in turbidostat competition to regulation by growth rate. Only the genes significantly regulated
by growth rate are shown. A. The overlap between HFC genes identified by selection in turbidostats (this work) and up-regulation at high
dilution rates [2] is significant. B. No significant correlation can be found between a gene’s expression being regulated by growth rate and its
FCC’ value in turbidostat culture.
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ortholog RNF8 regulates the G2/M DNA damage check-
point [18], and EPL1, a component of the NuA4 com-
plex, which has also been linked to DNA repair [19].
We will now discuss in more detail the set of haplopro-
ficient genes involved in the maintenance of genome
integrity.
Genome integrity related functions are tightly linked
to cell cycle as replication of genome requires timely
functioning of various protein and protein complexes
regulated by cell cycle. 207 of the 384 genes annotated
to the GO term ‘chromosome organisation’ are HFC
genes. Many of these genes, as well as others, are
directly involved in the maintenance of genome integrity
and also show a haploproficient phenotype. These genes
and their functions (some 42 of them are listed in Addi-
tional File 6, Table S3). It is clear from the results of the
turbidostat competition experiments that yeast is
capable of growing at faster than maximum specific
growth rate of the wild-type strain. However, the
imperative of correctly replicating and segregating its
chromosomes, repairing DNA damage, and generally
maintaining its chromosome integrity has imposed
restraints on the absolute rate of growth that can be
sustained over evolutionary time.
Growth-Rate Control is a Complex Function of Protein
Activity
The relationship between gene copy number and protein
levels is an important factor that must be taken into
consideration when investigating growth-rate control.
Torres and co-workers [20] have reported that aneu-
ploid yeast cells overexpress the genes on the extra
chromosomes (93% of the genes on the extra chromo-
somes were found to be overexpressed by at least a
Figure 3 Range of FCC’ values for HFC genes belonging to the categories shown in Additional Figure 2. On the left, light blue bars show
the range of FCC’s of significantly HI genes with smaller magnitude than the average for the category, dark blue bars shown the range of FCC’s
of significantly HI genes with larger magnitude than the average for the category (the junction of the light and dark blue bars is the average
FCC’ of the category). On the right, light red bars show the range of FCC’s of significantly HP genes with smaller magnitude than the average of
the category, dark red bars show the range of FCC’s of significantly HP genes with larger magnitude than the average of the complex (the
junction of the light and dark red bars is the average FCC’ of the complex). It should be noted that ranges of FCC’ values for HI genes are larger
than those for HP genes. The numbers in parentheses give the number of genes in the category with data from competition experiments.
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factor of 1.3-fold compared to the wild-type haploid
parent). Recently, it has also been reported that, for
most genes tested, the average level of their protein pro-
duct is proportional to gene copy number, which indi-
cates that dosage compensation is a rare event [21].
Springer and co-workers [21] investigated 643 genes
and 123 of them were found to have significant levels of
dosage compensation when one copy was deleted from
the genome, while 18 genes reduced their expression to
less than half of the wild-type level, when one copy is
deleted from the genome. We reasoned that more HI
genes should be found in the set of genes that exhibit
no dosage compensation and more HP or non-HFC
genes in the set of genes that exhibit some dosage com-
pensation. This is because a lack of dosage compensa-
tion is more likely to result in inadequate protein
concentrations in the cell, and thus result in a reduction
of fitness. Genes with dosage compensation would be
expected to have less growth-rate control as the concen-
trations of their protein products in a hemizygote will
be closer to those in the wild type. Furthermore, haplo-
proficiency can be expected if dosage compensation
leads to product levels that exceed those of the wild
type. We have compared the dosage compensation
values [21] (log2 transformed fold changes, 0 indicates
no dosage compensation, 1 indicates dosage compensa-
tion that matches the wild-type level of the protein) to
FCC’ values from turbidostat competitions and the over-
lap of HFC genes to genes with or without significant
dosage compensation.
The genome-wide frequency of HI genes identified in
our turbidostats is 34%, while the frequency of HI genes
in the sets of genes with and without dosage compensa-
tion is 25% and 33% (31/123 and 167/502), respectively
(Figure 5A), indicating that HI genes are only slightly
underrepresented in the set of genes with dosage com-
pensation (hypergeometric p-value = 0.0246), rather
than being depleted. Thus, there is no significant corre-
lation (Figure 5B) between genes showing dosage com-
pensation and those with an HFC phenotype in
turbidostats or in any of the other conditions that we
investigated. This indicates that there is no simple rela-
tionship between either a protein’s level orthe dosage
compensation of its cognate gene and the HFC charac-
teristics of that gene.
It was further reported by Springer and co-workers
[21] that dosage compensation remains the same for a
protein across different growth conditions. If dosage
compensation (or the lack of it) was a simple indication
of high growth-rate control, then we would expect to
find a similar set of HFC genes in different conditions,
and flux control coefficients to be (negatively) correlated
to dosage compensation, both of which we failed to
find. Hence, it should be realised that the flux control
exerted by a protein is a function of its biological activ-
ity (which is probably context dependent), rather than
simply on its molecular abundance. None of the high-
throughput studies (including our own) measures biolo-
gical activity, and so it might be anticipated that FCC’
values are a complex function of protein abundance.
Few other factors were shown to link protein abundance
to growth-rate control. For example, Sopko and co-work-
ers [22] found that ca. 15% of the genes in yeast are toxic
when overexpressed; that is, their overexpression reduced
the growth rate. This set of toxic genes was enriched in
cell cycle genes, particularly in genes that are expressed
periodically. This finding supports the hypothesis that a
protein can be toxic even at its wild-type levels and thus
the expression of its cognate gene has to be carefully con-
trolled. Such toxicity may increase as the protein abun-
dance increases. It follows that a reduction in the
concentration of a protein that acts as an inhibitor of
growth at its wild-type concentration can have a positive
impact on growth rate. Yoshikawa and co-workers [23]
reported that deletion and overexpression mutants of
more than 400 genes have growth defects. (Note that very
Figure 4 The effect on of hemizygous deletions on progress
through the cell cycle. The percentage of cells in G1 phase of the
cell cycle during exponential growth is shown on the vertical axis
for 120 heterozygous deletion mutants. The mean length of G1 as a
percentage of the total length of the cell cycle is shown for all
strains (bars show ± 1 standard deviation from the mean). The HO/
ho mutant strain used as a control is shown in blue. Strains
showing changes in the cell cycle > 1 sd and significant
haploproficiency (P < 0.001) in one or more of the D > = 0.3 h-1
experiments are highlighted in red, along with cyclin gene CLB2,
which does not show haploproficiency, but shows a strong cell
cycle phenotype.
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few deletion or over-expression mutants that have a haplo-
proficient phenotype were found -probably because of the
low sensitivity of measurements in batch culture in micro-
titre plates). Another factor that should be considered is
dosage imbalance as a result of deviation from wild-type
protein levels ([24-27]).
Kacser and Burns [1] have described the relationship
between enzyme activity and flux as a monotonic curve
that converges to a saturation level (Figure 6). This curve
implies that changes in enzyme activity in the ‘undetect-
able range’ do not have a major impact on flux, while
small changes can be more easily detected within the
‘detectable range’. However, this view of dosage versus
flux is limited for two reasons: (i) Only enzymes are con-
sidered, hence increasing an enzyme’s level either
increases the flux or has no effect on it (monotonic). (ii)
It was assumed that enzymes are unlikely to have a muta-
tion that will increase their activity (and that, even if they
did, the effect would be in the ‘undetectable’ range).
Indeed, we have not found any enrichment of genes that
encode enzymes in our set of HFC genes. Hence, a
saturation curve will not explain the phenotypes observed
in a genome-wide screening of HI and HP mutants.
In order to explain our results with a dosage v. flux
curve, we have to extend its applicability to all the cases
we observe and we should expect to find a different
curve for each protein. For example, the lack of correla-
tion between dosage compensation and high flux control
demonstrates that the threshold lies at a different level
of activity for each gene or protein. Further, haploprofi-
ciency cannot be explained by a curve that converges to
a saturation level, as the maximum growth rate of a
heterozygous mutant can be no higher than the maxi-
mum growth rate of the wild type on such a curve.
Therefore, the flux and the control exerted on it by a
protein have to be the outcome of multiple factors, each
of which can be hypothesized to be a non-linear func-
tion of gene (protein) dosage/activity. The activity v.
flux curve shown in Figure 6 has to be coupled with
additional functions that explain the contributions or
limitations imposed on the growth rate by the protein -
either due to its toxic effects and functional inhibition
on growth, or to the imbalances that result from
changes in its abundance.
Figure 6 The classical view of the enzyme - flux relationship
(Kacser and Burns, 1981). Reproduced with permission (copyright
is retained by the Genetics Society of America).
Figure 5 Comparison of FCC’s of genes in turbidostat competition to dosage compensation. Only the genes studied by Springer and co-
workers [42] are shown. A. The overlap between HFC genes in turbidostats and genes with compensation or exacerbation is not significant. B.
No significant correlation (Spearman rho = 0.016, p-value = 0.69) can be found between dosage compensation and FCC’. (Note: Correlation of
FCC’ to dosage compensation reported by Torres and co-workers’ [20] is rho = 0.01, p = 0.83).
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In conclusion, we hypothesize that a more realistic
representation of the link between protein abundance
and flux control can be achieved by a superimposition
of curves, as shown in Figure 7A. We have extended the
classical view shown on Figure 6 by including four more
factors:
1. The possibility of non-zero flux, even if the pro-
tein concentration is zero, and the possibility of
achieving higher fluxes as the protein concentration
is increased to higher levels than in the wild type.
The former possibility applies to non-essential genes
in a diploid organism, and the latter to proteins that
increase the flux when they are over-expressed.
2. Dosage imbalance: Components of the tubulin
complex [24] and cell-cycle-related processes [27]
have been shown to cause dosage imbalance if their
concentration deviates from wild-type levels.
3. Inhibition by toxicity: Over-expression of hun-
dreds of genes has been shown to cause toxicity [22]
and [23]; the mechanism of toxicity is not known for
most of these genes.
4. Functional inhibition: The function of many pro-
teins is the inhibition or delay of processes that lead
to cell growth. The timing and level of expression of
genes encoding such proteins is usually fine-tuned by
the cells to avoid unwanted inhibition of growth. Our
results indicate that cell cycle checkpoint proteins
may exert a significant inhibition on growth rate.
Hypothetical examples of such curves are given in
Figures 7B-D. It is likely that genes with curves as
shown in Figures 7C and 7D constitute a considerable
fraction of the genome, rather than being exceptional
cases. Revealing the superimposed fitness curve for each
gene requires data on growth rates at various gene copy
numbers (or protein concentrations), examples of which
are starting to appear in the literature (Alcasabas and
co-workers (submitted); [28]).
Two examples of applicability of these principles are
shown on Figure 8. Average slope of gene copy number
- phenotype curve for genes encoding cytosolic riboso-
mal proteins is significantly positive in turbidostat selec-
tions; however, it is very close to zero in nitrogen-
Figure 7 Phenotype-gene copy number relationships. A. Hypothetical relationship between phenotype and gene copy number. B-D
Hypothetical examples of superimposed phenotype-gene copy number curves.
Pir et al. BMC Systems Biology 2012, 6:4
http://www.biomedcentral.com/1752-0509/6/4
Page 10 of 16
limited competitions. This indicates that cells with
reduced numbers of ribosomes can still grow at the
population average under nitrogen limitation, probably
because competition is not for rapid synthesis of pro-
teins. However, having reduced ribosomal protein gene
copies in turbidostats caused growth deficiency, indicat-
ing that protein synthesis is rate-determining in turbido-
stats. Hence, on average, the protein components of
cytosolic ribosomes have detectable growth-rate control
under the turbidostatic conditions, but not under nitro-
gen limitation. The range of FCC’ values for HFC genes
encoding components of cytosolic ribosomes is shown
in Figures 8B-C. Similarly, the average slope of the copy
number - phenotype curve for genes specifying protea-
somal proteins is significantly positive in turbidostat
selections. However, the value of the slope is smaller in
nitrogen-limited cultures at high growth rates and finally
changes its sign to negative at D = 0.2 h-1 and to an
even lower value at D = 0.1 h-1 (Figure 8D). Both ribo-
somal and proteasomal proteins span a large range of
negative FCC’s while proteasomal proteins span the lar-
gest range of positive FCCs’, indicating the variation of
FCCs’ within a protein complex and context dependency
of flux control. Hence the dosage vs flux curve for a
protein identifies how its function, toxicity, imbalance,
abundance, or redundancy reflects on the growth rate.
Discussion
Haploinsufficiency is the situation where the reduction
in the copy number of a gene in a diploid organism
from two to one results in a significant loss of fitness. It
is assumed that the reduction in copy number results in
a corresponding reduction in the concentration of the
gene’s protein product, such that there is insufficient of
that protein present to sustain the wild-type phenotype.
The connection of haploinsufficiency to diseases has
long been known [29-31] and various hypotheses have
been proposed to explain the mechanisms of haploinsuf-
ficiency ([26,25]). The kinetics of gene expression in
connection to haploinsufficiency has also been studied
[32]. Haploinsufficiency was initially identified in gene-
by-gene phenotype screenings in humans and other
organisms. However, the availability of a genome-wide
collection of deletion mutants, as well as tag arrays for
quantifying the proportions of individual mutants in a
population, has enabled genome-wide screening for phe-
notypes of S. cerevisiae deletion mutants under various
conditions ([5,33,4]). Previously, sets of HFC genes have
been reported for the following cell populations grown
in batch culture: (i) homozygous deletion mutant pool
growing in YPD [5]; (ii) both homozygous and heterozy-
gous pools growing on fermentable and non-fermentable
carbon sources [34]; and (iii) heterozygous and homozy-
gous pools growing in YPD and minimal medium [35].
Some of these pools have also been screened for hap-
loinsufficiency when treated with drugs and sets of
genes with drug sensitivity and resistance have been
identified ([36-38]).
Haploproficiency under fast growth rate conditions
has not been reported until recently [39] in genome-
wide phenotype screenings of S. cerevisiae. However, it
has been reported that it is possible to select for
mutants with 5-50% increase in growth rate (as com-
pared to wild type) under specific nutrient limitations
Figure 8 Phenotype of genes encoding components of protein complexes as a function of copy number is context dependent. A.
Cytosolic ribosomal proteins have positive slope in turbidostats B-C. The range of significant FCC’s for cytosolic ribosomal proteins. D. Sign of
slope of the phenotype-copy number curve for genes specifying proteasome subunits. E-F. Range of significant FCC’s for proteasomal proteins.
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[40]. Some of these evolved strains had transporter gene
amplifications, together with other mutations not asso-
ciated to related physiology. It was later reported that
Kluyveromyces marxianus [41], allowed to evolve in a
mineral medium, can attain higher growth rates than
the mother strain. Changes in the morphology of these
cells were found to be linked to the increased maximum
growth rate, probably because a larger surface area (rela-
tive to cell volume) of the elongated mutants allows
transport processes to take place more efficiently. See
the review by Cakar and co-workers for recent
approaches in evolutionary engineering of strains [42].
Although data on the evolution of strains have pro-
vided a valuable resource for elucidating the mechan-
isms of growth rate control, systematic screens of
single-gene deletion mutants provide genome-wide pro-
filing of all known genes. While mutants with severe
growth defects can be easily detected in such screenings,
it has been difficult to detect single-gene deletion
mutants which grow faster than the wild type, as the
difference in growth rate can be small and below the
threshold of detection. This hindered the identification
of haploproficient hemizygotes in many studies. We
have shown that competition at slow growth rates in
nutrient-limited chemostats can be used to identify
growth advantages as well as growth deficiencies at high
sensitivity [4]. Most of the genes only displayed haplo-
proficiency under a particular nutrient limitation; for
example, most genes encoding subunits of the 26S pro-
teasome were HP under nitrogen limitation at D = 0.1
h-1 [4]. The reason for their haploproficiency under
these conditions is unknown; however, it is likely to be
a positive outcome of reducing the rate of protein turn-
over when there is competition for nitrogen resources.
In a recent study on Schizosaccharomyces pombe [39],
136 heterozygous deletion mutants in competition were
shown to have faster growth rates than wild type when
grown in batch on a rich medium. The same study also
reported 183 haploproficient S. cerevisiae genes derived
from a re-analysis of previously published data from a
competition of heterozygous deletion pools under simi-
lar conditions [35]. Screening of a library of hypo-
morphic alleles of essential genes also revealed a small
set of faster-growing mutants with a reduced concentra-
tion of essential proteins [43]. In this study, we have
identified a large set of haploproficient as well as hap-
loinsufficient hemizygotes using S. cerevisiae cultures
growing at their maximum growth rates. Although these
results are novel, it is not surprising that reducing the
level of proteins that act as negative regulators of pro-
cesses required for rapid growth, or that are toxic as
monomers in the cytosol, can have a positive impact on
growth rate. Although we might expect such growth-
rate-limiting factors to be eliminated by evolution in
order to attain yet higher growth rates and thus greater
fitness, it is possible that these factors were optimized
rather than eliminated, without compromising the basic
function of the protein, which may be essential under
sub-optimal conditions.
Our HI gene set includes 124 of the 186 HI genes
reported by Deutschbauer and co-workers [35] (GR <
0.97) (our set had data on 166 of the 186), while 8 of
the 166 are significantly HP in our set. Our HP gene set
includes only 21 of the 181 HP genes reported by
Deutschbauer and co-workers [35] (GR > 1.03), 178 of
which exist in our data set. 46 of these genes are HI in
our set, demonstrating that the results from the two
experiments vary significantly with respect to the identi-
fication of the HP phenotype. There can be a number of
reasons for the discrepancy between the two datasets.
First, our classification criteria are based on goodness-
of-fit rather than the percent change in growth rate - so
mutants with small, but significant, changes are included
in our HFC set, while mutants with large changes may
have been excluded if their readings were noisy. More-
over, the experimental regimes used in the two studies
are different since continuous turbidostats were used in
this study as opposed to batch shake flasks. Finally, both
experiments are expected to have some level of stochas-
ticity in both the competition and sampling steps, and
downstream processing of the samples may also intro-
duce noise into the final results.
Features of genes and proteins are not globally
correlated to flux control
Haploinsufficiency can be linked to a number of factors,
and previous authors have found evidence for the HI
phenotype of hemizygous deletants being the result of
either the insufficient concentration of the protein
encoded by the single-copy gene or of dosage imbalance
[35]. Noise in gene expression has also been proposed
as a reason for haploinsufficiency ([32,44]), while Veitia
[45] suggested synergistic interactions between tran-
scription factors (TF) as the cause of the haploinsuffi-
ciency of TF mutants. Accordingly, we compared our
FCC’ measurements to data from the literature to deter-
mine whether these, or any other factors, had an impor-
tant impact on FCC’ values in rapidly growing yeast.
Haploinsufficiency is often described as a direct conse-
quence of inadequate concentrations of proteins [35], so
it can be hypothesized that the proteins with higher
abundance will have higher flux control when their gene
copy number is reduced - particularly if dosage compen-
sation in hemizygous mutants is rare, as reported by
Springer and co-workers [21]. However, we found no sig-
nificant correlation between protein abundance [46] and
high flux control at rapid growth. It was also hypothe-
sized that proteins with noisy expression are more likely
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to fall below the threshold [31] that will cause irreversible
growth defects. We have compared modified flux control
coefficients to noise in mRNA expression (DV values
from [47]). There was no genome-wide correlation
between high growth-rate control and noise in mRNA
expression, nor were the rates of mRNA and protein
decay or half-lives [48-50] correlated to growth-rate con-
trol. In a recent study on haploinsufficiency in humans
[51], genetic interaction network features were identified
as the best predictors of haploinsufficiency. However, the
correlation between the number of genetic interactions
of genes and their FCC’ value in our turbidostat study
were insignificant (rho = -0.049 for positive interactions,
-0.055 for negative interactions, -0.015 for synthetic
lethal, rho = -0.065 for all physical and genetic interac-
tions of yeast from BioGrid, [52]). We have also demon-
strated that, although growth-regulated genes (from our
Category 1 experiments) are, themselves, controllers of
flux at the fastest growth rates, there is no simple rela-
tionship between the change in growth rate due to hap-
loinsufficiency and the fold change in transcript level or
protein concentration.
Haploinsufficiency has been linked to the stoichiome-
try of protein complexes as there is evidence that dosage
imbalance has a profound effect on phenotype in some
cases ([25,29]). Previous competition experiments on
homozygous and heterozygous deletion mutant pools
grown in batch on YPD have also shown that genes
encoding the components of protein complexes are
enriched among the HI genes [35]. Our HFC genes are
also enriched in genes encoding components of protein
complexes (hypergeometric distribution, p-value = 1.5e-7
for HI genes, p-value = 0.034 for HP genes; the genes
assigned to GO Term ‘protein complex’ were used in
the analysis (Saccharomyces Genome Database, SGD,
http://www.yeastgenome.org). Moreover, HI genes and
their protein products are involved in more genetic or
protein-protein interactions than expected by chance (p-
value = 8.7e-7 for HI as opposed to p-value = 0.22 for
HP, data from Biogrid [52]). Both HI and HP genes are
more likely to be essential than the average for the gen-
ome (hypergeometric distribution, p-value = 0.0051 for
HI genes and p-value = 0.039 for HP genes; list of
essential genes downloaded from SGD). These results
demonstrate that protein complexes, or proteins that
function in interaction with others, are more likely to be
involved in high flux control when compared to proteins
that act as singletons in the cell.
Conclusions
Our method has identified many more HI and HP genes
than have been reported previously. Our results cover
124 of the 166 HI genes previously identified in YPD
[35]. The relatively poor overlap with previous data on
HP genes indicates systematic differences between
experimental design and data analysis regimes in the
two different approaches.
We find that translation and transcription are the bot-
tlenecks for fast growth when the nutrients are not lim-
ited. The enrichment of cell cycle genes in the set of
genes that are toxic upon over-expression supports our
hypothesis that reduction in protein levels increases
growth rate as wild-type levels limit the growth rate by
‘functional inhibition’. Accumulation of cells in the G1
phase may be an indication of its high flux control,
although no direct link exists between the two. Genes
involved in the maintenance of genome integrity also
show a haploproficient phenotype under conditions of
rapid growth. Thus the checks and balances that the
yeast cell imposes on itself to ensure that its genome
integrity is maintained and that the genome is faithfully
replicated and segregated during the cell cycle limit the
absolute rate of growth which is compatible with the
organism’s long-term survival.
Proteins may have different levels of flux control
under different growth conditions; their flux control can
even be in opposite directions depending on the nature
of the competition. Hence, high flux control is context-
dependent and is not a direct consequence of any single
factor, such as protein abundance or growth-rate regula-
tion of gene expression. It is more likely to be a com-
plex function of protein activity, which can be
hypothesised as a superimposition of functions set by
multiple factors.
Methods
Competition Experiments
A 1 ml aliquot of the heterozygous deletion mutant
(BY4743, MATa/MATa his3Δ1/his3Δ1 leu2Δ0/leu2Δ0
lys2Δ0/LYS2 MET15/met15Δ0 ura3Δ0/ura3Δ0) pool
(obtained from the Yeast Genome Deletion Project
library and prepared as described in Additional File 1,
Additional Methods) were grown in 100 ml of YPD
media overnight at 30°C with shaking at 180 rpm. 10 ml
of this preculture was used to inoculate 1L of the appro-
priate nitrogen-limited or FPM growth media in 2L fer-
mentors. Cultures were grown overnight at 30°C with
aeration and stirring at 750 rpm. After 24 hours the fer-
mentors were switched to continuous growth with pH
control (set point = 4.5) and either a fixed dilution rate
(chemostat) or dilution rate determined by biomass (tur-
bidostats). In turbidostat mode [53], the biomass corre-
sponding to approximately half of the maximum reading
from batch phase (corresponding to mid-exponential
growth). 20 ml samples were taken from the preculture
and overnight batch culture followed by at least four at
approximately 24-hour intervals from the continuous
cultures. Experiments were made with at least two
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biological replicates for each fermentation and two tech-
nical replicates for each sample. For further details on
fermentations including instrumentation and sampling,
see the Additional File 1, Additional Methods section.
DNA extraction, tag amplification, hybridization
Total DNA was isolated from each of the samples using
a Promega Wizard Genomic DNA purification kit,
according to the protocol provided together with the kit.
Universal primers were then used to amplify the up-tag
and down-tag sequences with separate PCR reactions as
described previously [4]. The PCR products were puri-
fied, quantified and hybridized on custom Affymetrix
Tag3/4 arrays as described previously ([4,54]).
Data analysis
Tag3 data were normalised and modelled as described
previously [4]. Tag4 data were normalized as described
[54] and modelled as described previously [4]. In both
cases a relative growth rate and multiple testing cor-
rected P-value (null hypothesis that relative growth rate
is equal to 0) were obtained for each strain. The 182
deletion mutants listed in [55] were excluded from
further analysis. The relative growth rates were used to
calculate the Spearman correlation coefficients between
experiments shown in Figure 1B. In Figure 1B the den-
drogram showing the relationship between different
experiments was constructed using the Euclidean dis-
tance between rows (experiments) and complete linkage
hierarchical clustering. The functional analysis was
made using Gene Ontology [56] as described in the
Additional File 1, Additional Methods. All statistical
methods were implemented either in R/Bioconductor
[57] using RSRuby [http://rubyforge.org/projects/rsruby/
] or Matlab [The Mathworks, Inc]. For further details
on sample processing and data analysis, see the Addi-
tional File 1, Additional Methods section.
Derivation of modified flux control coefficients
Equation 1 shows the change in abundance of a mutant
in a chemostat (or turbidostat) as a function of time:
dX
dt
= μX − DX (1)
Where X denotes hemizygote concentration (abun-
dance in terms of number of cells, in arbitrary units) in
the chemostat, t denotes time, μ denotes the growth
rate of the mutant and D is the dilution rate, which is
equal to the average growth rate of the population.
After rearranging Equation 1, a linear relationship
between the change of log.-transformed hemizygote
concentration and change in time can be derived (Eq.2).
Thus, linear regression of log.-transformed hemizygote
content of the samples with respect to time allows us to
calculate the relative difference between the growth rate
of the hemizygote and the population average (D)
d(lnX)
dt
= μ − D (2)
Each mutant in the heterozygous deletion pool has
half the wild-type copy number of one of its genes
(reduction from two copies to one), and the change in
the gene copy number introduces a deviation from D,
so the relative growth rate of a mutant linearly relates
to the ‘alternative deviation index’ (an approximation to
the flux control coefficient, or FCC, for large perturba-
tions; [58]) of the gene copy number of the correspond-
ing gene:
DI =
∂μ/D
∂copy number/copy number
≈ μ/D
copy number/copy number
= A
(
μ − D
2 − 1
)
= A
d(lnX)
dt
(3)
where A is the scaling factor (initial copy number/D).
Since A is a constant that applies to all mutants in the
pool, the relative growth rates of the mutants can be
used to represent the FCC of the corresponding gene
with the reduced copy number. We will call this quan-
tity the “modified FCC” or FCC’:
FCC′ =
d(lnX)
dt
(4)
Note that the FCC’ value of a gene depends on the local
slope of a protein concentration vs fitness curve at the
range of interest (Figures 6 and 7 give examples of such
curves). For example, the FCC’ of an essential gene can
be very high in the range of 0 copies to 1 copy (change in
flux in heterozygous deletion mutant with respect to the
inviable null mutant), or the FCC’ of a gene whose pro-
tein product is at a concentration higher than needed in
the wild-type cell (i.e. a level beyond saturation) would be
close to zero at proximity of the wild-type level. In this
study, the relative growth rate (or FCC’) gives the nega-
tive average slope of the protein concentration vs fitness
curve between 1 copy and 2 copies of each gene, i.e. our
HI genes with negative FCC’s indicate a positive flux con-
trol by the gene when its copy number is increased from
1 to 2, and similarly our HP genes indicate a negative
flux control. These principles apply both for gene copy
number and for protein abundance, based on the
assumption that diploid cells with only one copy of a
gene always have a lower concentration of its protein
product than the cells with two copies.
Cell cycle analysis
Cell cycle profiles were determined using the method
described in Haase and co-workers [59]. Briefly, cultures
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were grown to exponential phase before fixation in 70%
v/v ethanol, followed by RNase A and protease treat-
ment. Washed samples were then mixed with 1 μM
Sytox Green and analysed for DNA content in a Beck-
man Coulter CyanADP flow cytometer. 20,000 events
were captured for each sample with three biological
replicates (separate cultures) for each strain. Two peaks
were fit to the count histogram of DNA content using
the Dean-Jett-Fox method [60] and the percentage of
the total cells under the G1 peak was recorded for each
sample.
Additional material
Additional file 1: Additional Text and Methods. Additional text on
results and details on methods are provided.
Additional file 2: Figure S1. Histogram of relative growth rates
(FCC’) of HFC genes and all genes in turbidostats. HI:
Haploinsufficient, HP: Haploproficient (FDR < 0.05 is the threshold for
significant HI and HP genes). FCC’s of 5713 genes (genome), 1932 HI
genes and 796 HP genes were binned into 50 intervals each.
Additional file 3: Table S1: Relative growth rates from the
experiments. Abbreviations: C, N, P: Carbon-, Nitrogen- or Phosphorus-
limited F1 media 01, 02, 03: Dilution rates in chemostats of 0.1, 0.2 or 0.3
h-1, respectively Turb: Turbidostat FPM: Footprinting media Columns: 1:
Systematic name of the ORF, one copy of which has been deleted in the
hemizygous diploids All columns denoted as .FCC’: Relative growth rate
(modified control coefficient) of the mutant in the corresponding
experiment. All columns denoted as .P: P-value for rejecting the
hypothesis that GR ≠ 0. All columns denoted as .FDR: False discovery
rate at the specified P-value.
Additional file 4: Table S2: GO analysis of the growth rates. Each
experiment is given on a separate spreadsheet. Abbreviations: C, N, P:
Carbon-, Nitrogen- or Phosphorus-limited F1 media 01, 02, 03: Dilution
rates in chemostats of 0.1, 0.2 or 0.3 h-1, respectively Turb: Turbidostat
FPM: Footprinting media Columns: 1: Internal database row number. 2:
GO term ID 3: Name of the GO term 4: Class of the GO term (MF:
Molecular Function, BP: Biological Process, CC: Cellular Compartment) 5:
Number of genes annotated to the GO term 6: Coeff: Logistic regression
coefficient b of the GO term. Positive values indicate enrichment of a GO
term among the haploproficient genes, negative values indicate
enrichment among the haploinsufficient genes. 7: Odd.ratio: Log odds
ratio of the GO term. 8: P-value: P-value for rejecting the null hypothesis
that b≠0 9: FDR: False Discovery Rate at specified P-value.
Additional file 5: Figure S2. Fraction of HFC genes related to
selected organelles, protein complexes, and cellular processes. Only
genes showing an HFC phenotype in turbidostat culture are considered.
The key on the top left gives the colour code used in the chart: Dark
blue gives the percent of significantly HI (FDR < 0.05) and dark red gives
the percent of significantly HP (FDR < 0.05).
Additional file 6: Table S3: Haploproficient genes involved in the
maintenance of genome integrity. Columns: 1. ORF name 2. Gene
name 3. Gene description 4. Relative growth rates (FCC’) 5. FDR: False
Discovery Rate.
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